New Lyme Disease Vaccine Shows Strong Results in Trial

Summary: A new vaccine for Lyme disease might be available soon! Drugmakers Pfizer and Valneva tested a vaccine called LB6V, and it prevented Lyme disease more than 70% of the time in people ages 5 and older. Lyme disease comes from infected tick bites. Early signs include a rash, fever, fatigue, and joint pain. If you don't treat it, it can cause major heart and nerve problems. Since there is no approved Lyme vaccine for humans right now, this is a huge step forward for outdoor lovers.

For more details, see rssapp-dermatologyadvisor-com at dermatologyadvisor.com/news/new-lyme-disease-vaccine-shows-strong-results-in-trial/ (opens in new tab)